Hypoxia causes the activation of NF-kappa B and the phosphorylation of I kappa B alpha of both tyrosine and serine residues (Meeting abstract). NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Hypoxia causes the activation of NF-kappa B and the phosphorylation of I kappa B alpha of both tyrosine and serine residues (Meeting abstract).

Proc Annu Meet Am Assoc Cancer Res; 35:A3808 1994. Unique Identifier : AIDSLINE ICDB/95605493
Koong AC; Chen EY; Giaccia AJ; Dept. of Radiation Oncology, Stanford University School of; Medicine, Stanford, CA 94305-5468


Abstract: Transcriptional regulation of gene expression by NF-kappa B is accomplished by translocation of NF-kappa B from the cytoplasm to the nucleus where it is able to bind DNA. The signals for NF-kappa B activation are diverse, but can be classified as protein kinase C (PKC) dependent (eg, oxidative stress) or PKC independent (eg, TNF). We reasoned that NF-kappa B was activated by hypoxia because previous data demonstrated an induction of HIV-1 replication by lowering O2 tensions. To determine whether NF-kappa B could be activated by hypoxia to bind DNA and promote transcription of the HIV promotor, we used immunoblot analysis to show an oxygen dependent dissociation of the inhibitory subunit I kappa B alpha from NF-kappa B, and an oxygen dependent increase in p65 nuclear translocation. This increase in nuclear translocation of p65 resulted in increased DNA binding and an oxygen dependent transactivation of a reporter gene construct containing the HIV promotor ligated to the bacterial chloramphenicol acetyl transferase (CAT) gene. Induction of HIV-CAT seemed to be mediated through NF-kappa B as hypoxia did not induce transcription of the HIV-CAT constructs in which the NF-kappa B binding sites were mutated. To demonstrate a direct link between changes in I kappa B alpha phosphorylation with NF-kappa B activation, we immunoprecipitated I kappa B alpha after varying times of hypoxic exposure and found that both its tyrosine and serine phosphorylation status increased while its threonine phosphorylation status remained unchanged. Furthermore, inhibiting either of these phosphorylation steps was enough to prevent I kappa B alpha dissociation from NF-kappa B and transactivation of the HIV-CAT reporter construct. These results suggest that in vivo, phosphorylation at both tyrosine and serine residues on I kappa B alpha are important regulatory steps in the activation of NF-kappa B.
Keywords: Binding Sites Blotting, Western Cell Hypoxia DNA/METABOLISM NF-kappa B/ANTAGONISTS & INHIB/*METABOLISM Oxygen/METABOLISM Phosphorylation Precipitin Tests Serine/*METABOLISM Trans-Activation (Genetics) Tyrosine/*METABOLISM ABSTRACTKWDbindingsitesblotting,westerncellhypoxiadna/metabolismnf-kappab/antagonists&inhib/KWDmetabolismoxygen/metabolismphosphorylationprecipitintestsserine/KWDmetabolismtrans-activation(genetics)tyrosine/KWDmetabolismabstract
950330
M9530826

Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .